Search Within

Ellin Berman

Formats
  1. Journal Article (95)
  2. Meeting Abstract (68)
  3. Conference Paper (6)
  4. Guidelines (2)
  5. Review (2)
  6. Book Section (1)
  7. Correspondence (1)
  8. Editorial (1)
Groups
  1. Adult Leukemia (176)
  2. Center for Hematologic Malignancies (176)
  3. Department of Medicine (176)
  4. Hematologic Malignancies, Division of (176)
  5. Sloan Kettering Institute Faculty (44)
  6. Molecular Pharmacology and Chemistry Program Faculty (41)

More Groups

People
  1. Bayard Clarkson (29)
  2. Timothy Gee (26)
  3. Martin Tallman (17)
  4. Peter Maslak (17)
  5. Sanford Kempin (17)
  6. David Scheinberg (15)

More People

Years
  1. 2025 (1)
  2. 2024 (6)
  3. 2023 (5)
  4. 2022 (4)
  5. 2021 (3)
  6. 2020 (7)

More Years

Publications
  1. Blood (54)
  2. Journal of Clinical Oncology (20)
  3. Journal of the National Comprehensive Cancer Network (12)
  4. Leukemia (11)
  5. Leukemia Research (6)
  6. Bone Marrow Transplantation (5)

More Publications

Publishers
  1. American Society of Hematology (55)
  2. American Society of Clinical Oncology (20)
  3. Nature Publishing Group (17)
  4. Harborside Press (12)
  5. Elsevier Inc. (9)
  6. American Association for Cancer Research (8)

More Publishers

Results (176)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase I study of a single high dose of liposomal daunorubicin combined with high dose cytarabine for adult patients with relapsed/refractory acute myelogenous leukemia (AML)
    Meeting Abstract

    Maslak, P.; Weiss, M.; Jurcic, J.; Cathcart, K.; Heaney, M.; Berman, E.; Soignet, S.; Scheinberg, D.; Ward, S.
    Blood (2000)

    Fulltext@MSK | Save
  • Recent advances in the treatment of acute leukemia: 1999
    Journal Article

    Berman, E.
    Current Opinion in Hematology (2000)

    Fulltext@MSK | Save
  • NCCN practice guidelines for chronic myelogenous leukemia
    Journal Article

    Berman, E.; Clift, R. A.; Copelan, E. A.; Emanuel, P. D.; Erba, H. P.; Glenn, M. J.; Greenberg, P. L.; Jones, R. J.; O'Brien, S.; Saba, H. I.; more...
    Oncology (Norwalk) (2000)

    Fulltext@MSK | Save
  • The Faderl/Kantarjian/Talpaz article reviewed [Chronic myelogenous leukemia: Update on biology and treatment ]
    Journal Article

    Berman, E.
    Oncology (Norwalk) (1999)

    Fulltext@MSK | Save
  • High dose idarubicin (HIda) with high dose cytarabine (HiDac) as induction therapy for newly diagnosed patients with AML
    Meeting Abstract

    Maslak, P.; Weiss, M.; Jurcic, J.; Jimenez, J.; Berman, E.; Golde, D.; Scheinberg, D.
    Blood (1998)

    Fulltext@MSK | Save
  • Long term survival in patients with acute myelogenous leukemia (AML) and favorable prognosis cytogenetic abnormalities
    Meeting Abstract

    Kossman, S. E.; Maslak, P. G.; Weiss, M. A.; Berman, E.; Jhanwar, S.; Scheinberg, D. A.
    Blood (1998)

    Fulltext@MSK | Save
  • Recent advances in the treatment of acute leukemia
    Journal Article

    Berman, E.
    Current Opinion in Hematology (1997)

    Fulltext@MSK | Save
  • Long-term follow-up of three randomized trials comparing idarubicin and daunorubicin as induction therapies for patients with untreated acute myeloid leukemia
    Journal Article

    Berman, E.; Wiernik, P.; Vogler, R.; Vélez-Gárcia, E.; Bartolucci, A.; Whaley, F. S.
    Cancer (1997)

    Fulltext@MSK | Save
  • Expand your differential
    Journal Article

    Waltzman, R. J.; Berman, E.
    Leukemia Research (1997)

    Fulltext@MSK | Save
  • Economic evaluation of G-CSF use in the therapy of adult acute myelogenous leukemia (AML)
    Meeting Abstract

    Maslak, P.; Weiss, M.; Berman, E.; Tyson, D.; Scheinberg, D.
    Blood (1996)

    Fulltext@MSK | Save